DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis

FRA:DMP • DE000A2GS5D8

39.275 EUR
-0.08 (-0.19%)
Last: Feb 26, 2026, 01:20 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Taking everything into account, DMP scores 5 out of 10 in our fundamental rating. DMP was compared to 52 industry peers in the Pharmaceuticals industry. Both the profitability and the financial health of DMP get a neutral evaluation. Nothing too spectacular is happening here. DMP has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • DMP had positive earnings in the past year.
  • In the past year DMP had a positive cash flow from operations.
  • DMP had positive earnings in each of the past 5 years.
  • Each year in the past 5 years DMP had a positive operating cash flow.
DMP.DE Yearly Net Income VS EBIT VS OCF VS FCFDMP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

  • DMP has a Return On Assets (5.48%) which is comparable to the rest of the industry.
  • DMP has a Return On Equity of 17.87%. This is comparable to the rest of the industry: DMP outperforms 59.62% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 7.26%, DMP is in line with its industry, outperforming 44.23% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for DMP is below the industry average of 14.12%.
Industry RankSector Rank
ROA 5.48%
ROE 17.87%
ROIC 7.26%
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
DMP.DE Yearly ROA, ROE, ROICDMP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • DMP has a Profit Margin of 10.00%. This is comparable to the rest of the industry: DMP outperforms 42.31% of its industry peers.
  • In the last couple of years the Profit Margin of DMP has declined.
  • DMP's Operating Margin of 18.70% is in line compared to the rest of the industry. DMP outperforms 50.00% of its industry peers.
  • In the last couple of years the Operating Margin of DMP has grown nicely.
  • The Gross Margin of DMP (66.57%) is comparable to the rest of the industry.
  • DMP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.7%
PM (TTM) 10%
GM 66.57%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
DMP.DE Yearly Profit, Operating, Gross MarginsDMP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DMP is creating some value.
  • The number of shares outstanding for DMP remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, DMP has about the same amount of shares outstanding.
  • Compared to 1 year ago, DMP has a worse debt to assets ratio.
DMP.DE Yearly Shares OutstandingDMP.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
DMP.DE Yearly Total Debt VS Total AssetsDMP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.28 indicates that DMP is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • DMP has a Altman-Z score (2.28) which is in line with its industry peers.
  • The Debt to FCF ratio of DMP is 6.15, which is on the high side as it means it would take DMP, 6.15 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.15, DMP is in line with its industry, outperforming 51.92% of the companies in the same industry.
  • DMP has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of DMP (1.44) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 6.15
Altman-Z 2.28
ROIC/WACC1.06
WACC6.86%
DMP.DE Yearly LT Debt VS Equity VS FCFDMP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • DMP has a Current Ratio of 2.20. This indicates that DMP is financially healthy and has no problem in meeting its short term obligations.
  • DMP has a better Current ratio (2.20) than 73.08% of its industry peers.
  • A Quick Ratio of 1.04 indicates that DMP should not have too much problems paying its short term obligations.
  • DMP has a better Quick ratio (1.04) than 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.04
DMP.DE Yearly Current Assets VS Current LiabilitesDMP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 28.01% over the past year.
  • The Earnings Per Share has been growing by 8.07% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 0.11% in the past year.
  • DMP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.00% yearly.
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%

3.2 Future

  • DMP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.68% yearly.
  • DMP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.40% yearly.
EPS Next Y11.31%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
EPS Next 5Y14.68%
Revenue Next Year-0.75%
Revenue Next 2Y1.49%
Revenue Next 3Y2.17%
Revenue Next 5Y2.4%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DMP.DE Yearly Revenue VS EstimatesDMP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
DMP.DE Yearly EPS VS EstimatesDMP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.27, DMP is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of DMP indicates a somewhat cheap valuation: DMP is cheaper than 61.54% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of DMP to the average of the S&P500 Index (27.05), we can say DMP is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 15.60, which indicates a correct valuation of DMP.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DMP indicates a somewhat cheap valuation: DMP is cheaper than 69.23% of the companies listed in the same industry.
  • DMP is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.27
Fwd PE 15.6
DMP.DE Price Earnings VS Forward Price EarningsDMP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • DMP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DMP is cheaper than 75.00% of the companies in the same industry.
  • 84.62% of the companies in the same industry are more expensive than DMP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.86
EV/EBITDA 9.84
DMP.DE Per share dataDMP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • DMP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.62
PEG (5Y)2.26
EPS Next 2Y10.93%
EPS Next 3Y10.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • DMP has a Yearly Dividend Yield of 2.38%.
  • DMP's Dividend Yield is a higher than the industry average which is at 1.89.
  • Compared to an average S&P500 Dividend Yield of 1.80, DMP pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.38%

5.2 History

  • The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
DMP.DE Yearly Dividends per shareDMP.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • DMP pays out 41.76% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of DMP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP41.76%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
DMP.DE Yearly Income VS Free CF VS DividendDMP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DMP.DE Dividend Payout.DMP.DE Dividend Payout, showing the Payout Ratio.DMP.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DERMAPHARM HOLDING SE

FRA:DMP (2/26/2026, 1:20:01 PM)

39.275

-0.08 (-0.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-13
Earnings (Next)03-17
Inst Owners11.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.11B
Revenue(TTM)1.16B
Net Income(TTM)116.03M
Analysts78.18
Price Target42.84 (9.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.38%
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP41.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 18.27
Fwd PE 15.6
P/S 1.82
P/FCF 12.86
P/OCF 10.24
P/B 3.26
P/tB N/A
EV/EBITDA 9.84
EPS(TTM)2.15
EY5.47%
EPS(NY)2.52
Fwd EY6.41%
FCF(TTM)3.05
FCFY7.78%
OCF(TTM)3.84
OCFY9.77%
SpS21.55
BVpS12.06
TBVpS-7.73
PEG (NY)1.62
PEG (5Y)2.26
Graham Number24.15
Profitability
Industry RankSector Rank
ROA 5.48%
ROE 17.87%
ROCE 11.89%
ROIC 7.26%
ROICexc 7.91%
ROICexgc 21.74%
OM 18.7%
PM (TTM) 10%
GM 66.57%
FCFM 14.17%
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexgc growth 3Y-9.69%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 6.15
Debt/EBITDA 3.09
Cap/Depr 49.31%
Cap/Sales 3.63%
Interest Coverage 4.01
Cash Conversion 68.3%
Profit Quality 141.71%
Current Ratio 2.2
Quick Ratio 1.04
Altman-Z 2.28
F-Score7
WACC6.86%
ROIC/WACC1.06
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
EPS Next Y11.31%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
EPS Next 5Y14.68%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
Revenue Next Year-0.75%
Revenue Next 2Y1.49%
Revenue Next 3Y2.17%
Revenue Next 5Y2.4%
EBIT growth 1Y5.29%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.22%
EBIT Next 3Y19.63%
EBIT Next 5Y7.01%
FCF growth 1Y-31.18%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-25.65%
OCF growth 3Y-7%
OCF growth 5Y14.89%

DERMAPHARM HOLDING SE / DMP.DE FAQ

What is the fundamental rating for DMP stock?

ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE.


Can you provide the valuation status for DERMAPHARM HOLDING SE?

ChartMill assigns a valuation rating of 5 / 10 to DERMAPHARM HOLDING SE (DMP.DE). This can be considered as Fairly Valued.


How profitable is DERMAPHARM HOLDING SE (DMP.DE) stock?

DERMAPHARM HOLDING SE (DMP.DE) has a profitability rating of 5 / 10.


What are the PE and PB ratios of DERMAPHARM HOLDING SE (DMP.DE) stock?

The Price/Earnings (PE) ratio for DERMAPHARM HOLDING SE (DMP.DE) is 18.27 and the Price/Book (PB) ratio is 3.26.


Can you provide the expected EPS growth for DMP stock?

The Earnings per Share (EPS) of DERMAPHARM HOLDING SE (DMP.DE) is expected to grow by 11.31% in the next year.